{"id":"W4415668960","doi":"10.1016/j.htct.2025.104824","title":"DARATUMUMAB PLUS BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (DVRD) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): SUBGROUP ANALYSIS OF TRANSPLANT- INELIGIBLE (TIE) PATIENTS IN THE PHASE 3 CEPHEUS STUDY","year":2025,"lang":"en","type":"article","venue":"Hematology Transfusion and Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"","keywords":"Multiple myeloma; Clinical endpoint; Daratumumab; Subgroup analysis; Post-hoc analysis; Population; Overall survival; Phases of clinical research; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003332506,0.0003067506,0.00103232,0.0008505853,0.0001144479,0.00001871513,0.0001360171,0.0001294744,0.00004709193],"category_scores_gemma":[0.00002622114,0.0001898554,0.0001005104,0.00130621,0.0001686941,0.00007930569,0.00001558766,0.0002881566,5.599236e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003867547,"about_ca_system_score_gemma":0.00007382718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002016253,"about_ca_topic_score_gemma":0.005827567,"domain_scores_codex":[0.9977334,0.0004023847,0.0005803403,0.0005263342,0.0003738007,0.0003837792],"domain_scores_gemma":[0.9987802,0.0005463712,0.00009300415,0.0003618487,0.000101129,0.0001174327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02448676,0.0101187,0.9482322,0.0001036965,0.000670897,0.0001540078,0.005621195,0.000007973127,0.000191767,0.0000121395,0.00001767383,0.01038294],"study_design_scores_gemma":[0.1387532,0.002420597,0.8553948,0.00008714384,0.0003992651,0.00000277475,0.0009816581,0.0005425168,0.001211576,0.000009129555,0.00005731964,0.0001400247],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958742,0.001041974,0.0001733743,0.0001559812,0.00002817849,0.002518344,0.00006046489,0.0000150971,0.0001324004],"genre_scores_gemma":[0.9965304,0.00266521,0.00009778239,0.0002841901,0.000002965576,0.0001688844,0.000213092,0.00001688073,0.00002065438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1142665,"threshold_uncertainty_score":0.7742079,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01286749453895294,"score_gpt":0.2869479553716445,"score_spread":0.2740804608326916,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}